>MetaBio went down because there were mistaken ideas about what was possible and what was not in the realm of metabolic therapeutics, and because proper corpora

>MetaBio went down because there were mistaken ideas about what was possible and what was not in the realm of metabolic therapeutics, and because proper corporate structure and adequate capital are always issues when attempting to survive predictable setbacks Like many startup failures, funding issues and corporate structure were more pivotal than the progress made on the actual problem.